ETIOLOGY AND PATHOGENESIS OF HERITABLE CONNECTIVE-TISSUE DISEASES

被引:17
作者
COLE, WG
机构
[1] Department of Orthopaedic Surgery, Royal Children's Hospital, Melbourne
关键词
CHONDRODYSPLASIAS; COLLAGEN; EHLERS-DANLOS SYNDROME; OSTEOGENESIS IMPERFECTA; SPONDYLOEPIPHYSEAL DYSPLASIA;
D O I
10.1097/01241398-199305000-00023
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
There are many heritable disorders of the connective tissues and many of them produce major musculoskeletal anomalies. The etiology of most of them is unknown, but collagen mutations have been characterized in osteogenesis imperfecta (OI), in some forms of the Ehlers-Danlos syndrome (EDS) and in some of the chondrodysplasias. These diseases, particularly OI, provide a model for investigation of other heritable connective tissue diseases in which the mutant genes have not yet been identified.
引用
收藏
页码:392 / 403
页数:12
相关论文
共 46 条
[11]  
Beighton P., Inherited Disorders of the Skeleton, (1988)
[12]  
Bonadio J., Saunders T.L., Tsai E., Goldstein S.A., Morris-Wiman J., Brinkley L., Dolan D.F., Altschuler R.A., Hawkins J.E., Bateman J.F., Mascara T., Jaenisch R., A transgenic mouse model of the mild dominant form of osteogenesis imperfecta, Proc Natl Acad Sci USA, 87, pp. 7145-7149, (1990)
[13]  
Byers P.H., Brittle bones-fragile molecules: Disorders of collagen gene structure and expression, Trends Genet, 6, pp. 293-299, (1990)
[14]  
Chan D., Cole W.G., Low basal transcription of genes for tissue-specific collagens by fibroblasts and lymphoblastoid cells: Application to the characterization of a glycine 997 to serine substitution in a 1(11) collagen chains of a patient with spondyloepiphyseal dysplasia, J Biol Chem, 266, (1991)
[15]  
Chan D., Lamande S., Mitranges K., Cole W.G., Bateman J.F., Regulation of collagen synthesis during ascorbate-induced extracellular matrix accumulation in vitro, Biochem J, 269, pp. 175-181, (1990)
[16]  
Cole W.G., Orthopaedic treatment of osteogenesis imperfecta, Ann NY Acad Sci, 543, pp. 157-166, (1988)
[17]  
Cole W.G., Osteogenesis imperfecta, Clin Endocrinol Metah, 2, pp. 243-265, (1988)
[18]  
Cole W.G., Campbell P.E., Rogers J.G., Bateman J.F., The clinical features of osteogenesis imperfecta resulting from a nonfunctional carboxy-terminal pro-al(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues, J Med Genet, 27, pp. 545-551, (1990)
[19]  
Cole W.G., Chan D., Chambers G.W., Walker I.D., Bateman J.F., Deletion of 24 amino acids from the proal(L) chain of type 1 procollagen in a patient with the Ehlers-Danlos syndrome type VII, J Biol Chem, 261, pp. 5496-5503, (1986)
[20]  
Cole W.G., Chan D., Lamande S., Mascara T., Bateman J.F., Correlation of clinical and molecular biological abnormalities in osteogenesis imperfecta, Connect Tissue Res I989, 21, pp. 91-97